Wednesday, August 27, 2025
HomeIndustries

Industries

Amytrx Therapeutic’s AMTX-100 CF3 Moves to Phase II Clinical Trial for Atopic Dermatitis

Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...

REGENXBIO Opens State-of-the-Art Gene Therapy Manufacturing Facility

REGENXBIO Inc. is celebrating the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility. Also Read: Updated Data for Janssen’s Bispecific Teclistamab Suggest...

CyanVac Announces Data from Preclinical Studies of Intranasal PIV5-based COVID-19 Vaccine Candidate CVXGA1

CyanVac LLC, a clinical-stage biopharmaceutical company developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector, announced preclinical data in a hamster...

Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, announced that...

MosoLabs Launches to Accelerate Build Out, Growth of the Helium 5G Network

MosoLabs, a company that designs and distributes innovative hardware and software for open, decentralized wireless networks, launched to provide users with exceptional products that...
0FansLike
0FollowersFollow
spot_img

Hot Topics